Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • FAQs
  • News
  • Contact
  • English
Menu Close
  1. Home>
  2. 2018>
  3. December>
  4. 29>
  5. 2018>
  6. New Year Address of Beroni Group
You are currently viewing New Year Address of Beroni Group

New Year Address of Beroni Group

  • Post author:admin
  • Post published:2018-12-29
  • Post category:2018

You Might Also Like

Read more about the article Beroni Group and UNSW Signing Ceremony and Press Conference for Phase II development of anti-cancer drug PENAO

Beroni Group and UNSW Signing Ceremony and Press Conference for Phase II development of anti-cancer drug PENAO

2018-03-29
Read more about the article Professor Walter Ian Lipkin of Columbia University visited Beroni Group

Professor Walter Ian Lipkin of Columbia University visited Beroni Group

2018-06-14
Read more about the article 2017-2018 Annual General Meeting of Beroni Group was held successfully

2017-2018 Annual General Meeting of Beroni Group was held successfully

2018-02-13

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (7)

What’s New

  • Beroni Group Wishing You Happy Mid-Autumn Festival！
  • Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)
  • Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
  • Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
  • Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu